Curat Global’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$117K Hold
300
– – 0.1% 123
2026
Q2
$135K Sell
300
-50
-14% -$18.5K 0.11% 121
2026
Q1
$102K Sell
350
-200
-36% -$65.7K 0.1% 129
2025
Q4
$193K Sell
550
-50
-8% -$16.9K 0.21% 95
2025
Q3
$193K Hold
600
– – 0.18% 97
2025
Q2
$233K Hold
600
– – 0.22% 93
2025
Q1
$261K Buy
+600
New +$241K 0.32% 87

Other funds holding ELV

Curat Global's ELV Position: Q3 2026 in Review

Curat Global held its Elevance Health (ELV) position steady in Q3 2026 at 300 shares worth $117K. The position accounts for 0.1% of the portfolio, ranked #123.

Curat Global first reported a position in ELV in Q1 2025 and has held it in 7 quarters since. The position peaked at $261K in Q1 2025. 556 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Curat Global held 300 shares of Elevance Health worth $117K as of Q3 2026.
  • Curat Global left its Elevance Health share count unchanged in Q3 2026.
  • Elevance Health made up 0.1% of Curat Global's portfolio in Q3 2026, its #123 holding.
  • Curat Global first reported a position in Elevance Health in Q1 2025 and has held it in 7 quarters since.
  • Curat Global's Elevance Health position peaked at $261K in Q1 2025.
  • 556 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Curat Global's 13F filing for Q3 2026, filed 26 Oct 2026.